You are here: Industry Insights > FDA

News List

Axio Biosolutions gets USFDA clearance for Axiostat Patch for vascular bleeding control expresspharma
July 01, 2021
Axio Biosolutions, an integrated wound care company has announced FDA 510(k) clearance of its hemostatic product Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, puncture sites and more.
CBD Products Gain Following Among Fibromyalgia Patients drugs
July 01, 2021
Could the answer to easing the tough-to-treat chronic pain and fatigue of fibromyalgia be found in edibles and other products containing CBD?
Apellis, Beam ink base-editing pact to tackle complement-driven diseases firstwordpharma
July 01, 2021
Apellis Pharmaceuticals and Beam Therapeutics have forged a five-year research partnership that will apply the latter's base-editing platform toward discovering new treatments for complement-driven diseases, the companies announced Wednesday.
Freeline Announces Executive Leadership Changes firstwordpharma
July 01, 2021
FRLN today announced the expansion of its executive leadership team with the appointment of James "Jay" Bircher as Chief Technical Operations Officer effective July 1, 2021.
FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease drugs
June 30, 2021
Sarfez Pharmaceuticals announced today approval by the U.S. Food and Drug Administration (FDA) of the Virginia-based company’s New Drug Application for Soaanz, a once-a-day improved formulation of the loop diuretic torsemide.
Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for Pedmark drugs
June 30, 2021
Fennec Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the resubmission of its New Drug Application (NDA) for Pedmark.
Genentech’s Actemra Receives FDA Emergency Use Authorization for the Treatment of COVID-19 In Hospitalized Adults and Children drugs
June 29, 2021
Genentech announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra (tocilizumab) for the treatment of COVID-19 in hospitalized adults and pediatric patients
Lilly's Donanemab receives U.S. FDA's Breakthrough Therapy Designation for Treatment of Alzheimer's disease drugs
June 29, 2021
The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for donanemab, Eli Lilly and Company's (NYSE: LLY) investigational antibody therapy for Alzheimer's disease (AD).
Glenmark gets USFDA nod for generic lung cancer drug expresspharma
June 28, 2021
Glenmark Pharmaceuticals yesterday said it has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer, in the American market.
FDA Approves Verkazia (cyclosporine ophthalmic emulsion) for the Treatment of Vernal Keratoconjunctivitis drugs
June 28, 2021
Santen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops for the treatment of vernal keratoconjunctivitis (VKC) in children and adults.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page